Study: Oral Nutritional Supplements Reduce Readmission Risk, Cost

Inpatients who received oral nutritional supplements, such as nutrition drinks, had a shorter length of stay, lower costs and a lower readmission risk than patients who did not receive supplements, according to a study in the American Journal of Managed Care.

Advertisement

The study, supported by healthcare company Abbott, examined adult inpatient cases in the Premier Perspectives database from 2000 to 2010. ONS patients’ length of stay was 8.6 days — 21 percent less than non-ONS patients’ 10.9-day length of stay. At $17,216, the cost of care for ONS patients was 21.6 percent less than the cost for non-ONS patients, which was $21,950.

When looking at only those patients who were readmitted at some point, ONS patients had a 6.7 percent lower likelihood of being readmitted early, defined as within 30 days, compared with non-ONS patients.

More Articles on Hospital Readmissions:

Johns Hopkins, HealthCare Access Maryland Partner to Cut Readmissions
3 Best Practices for ACOs’ Care Transition Programs
Pediatric Readmissions Aren’t a Useful Quality Measure, Study Suggests

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

When nurses help build the AI, adoption follows: Lessons from 3 health systems

Tuesday, July 28
11:00 AM - 12:00 PM CDT

Presenters: Amy McCarthy, DNP, RNC-MNN, NE-BC, CENP, Hippocratic AIBeth Reimschissel, PhD, RN, CNL, Memorial HermannAllison Schlinkert, MSN, RN, NPD-BC, Cincinnati Children'sScott Estep, MBOE, BSN, RN, CSSBB, OhioHealth System

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.